Posts Tagged ‘ Incontinence ’

Imaging Device: Translabial Ultrasound “Sees” Mesh

Jul 8th, 2014 | By
Imaging Device: Translabial Ultrasound “Sees” Mesh

“I have removed more than 900 mesh for complications in the last 5-6 years. Tranaslabial ultrasound is an important adjuvant to the diagnosis and treatment of this patients.” Those are the words of the leading mesh removal surgeon in the world, Dr. Shlomo Raz, MD in an exchange with Mesh News Desk. The Professor of Urology
[continue reading...]



June – Watching and Waiting for News of Mesh Settlements, Reclassification

Jun 2nd, 2014 | By

Tensions are beginning to get strained over the extremely long wait for justice for the mesh- injured. Welcome to Mesh News Desk aka MMDND your source for all news mesh-related. Much is happening at this time but much of it is behind the scenes.   Take for example, the recent announcement that Endo/AMS had decided to
[continue reading...]



*NEW* The Doctors: Risks of Mesh Implants for Bladder Control

May 21st, 2014 | By
*NEW* The Doctors: Risks of Mesh Implants for Bladder Control

“The one way I know how to describe it is “suicidal”  That’s  stabbed from the inside.” “There is nothing wrong with you its in year head, you might be crazy,” says the doctor. That’s the show “teaser for The Doctors, television show. It is not clear when this segment is running, though it appears May
[continue reading...]



Endo Offers $830 Million to Settle 20K AMS Pelvic Mesh Lawsuits

Apr 30th, 2014 | By
Endo Offers $830 Million to Settle 20K AMS Pelvic Mesh Lawsuits

*This Just In* Late this afternoon, Endo Health Solutions announced it had reached an agreement with several law firms to settle in principle about 20,000 defective pelvic mesh lawsuits sold by its subsidiary American Medical Systems. Here is Endo’s news release.   Here is Exhibit A: Resolution Framework: http://www.motleyrice.com/files/medical-devices/exhibit_a.pdf MR press release about the settlement
[continue reading...]



FDA: *IMPORTANT* How To Weigh in on Reclassifying Pelvic Mesh To High-Risk!

Apr 29th, 2014 | By
FDA: *IMPORTANT* How To Weigh in on Reclassifying Pelvic Mesh To High-Risk!

*NEW*  Readers of Mesh News Desk understand that the Food and Drug Administration has allowed  the polypropylene-based material onto the market to treat pelvic organ prolapse and incontinence with very little scrutiny.  In fact, the 510(k) approval process is an approval to sell, and does not require safety and efficacy assurances. Now the agency is
[continue reading...]



Day Five: Lewis v Ethicon: Ticking Time Bomb

Feb 15th, 2014 | By
Day Five: Lewis v Ethicon: Ticking Time Bomb

Lawyers for the plaintiff Carolyn Lewis (C.L.) wrapped up their defective product case against Ethicon (Johnson & Johnson) on Friday, February 14th, Valentine’s Day, capping off the day with C.L. on the stand. Before that there was more testimony via videotape from scientists working with Ethicon to show the company knew it had a problem
[continue reading...]



Autoimmune Diseases and Surgical Mesh – Causation or Correlation?

Jan 28th, 2014 | By
Autoimmune Diseases and Surgical Mesh – Causation or Correlation?

Writer and researcher Noni Wideman has been at it again, uncovering the links to many autoimmune diseases that seem to plague mesh-implanted persons. This  does not mean there is a cause-effect but certainly there is a correlation seen with many of these diseases cropping up among those who have had mesh implanted to treat prolapse,
[continue reading...]



MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

Dec 19th, 2013 | By
MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

The name of Dr. Dionysios Veronikis St. Louis is one that is increasingly heard among mesh-injured women.  Dr. Veronikis tells Mesh News Desk (MND) he now spends half of his time doing mesh removal surgeries, also known as explants, and although he still uses synthetic mesh on rare occasions, his surgical skills allow him to
[continue reading...]



Bard Opening Arguments in Federal Transvaginal Mesh Case

Jul 9th, 2013 | By
Bard Opening Arguments in Federal Transvaginal Mesh Case

July 9, 2013 ~“Our job together is to figure out the facts. Trust is a sacred and powerful thing. Although a corporation may be doing good work, if you find they failed in warning, making and manufacturing this device, you must hold them accountable.” That was the opening statement from attorney Henry Garrard who represents
[continue reading...]



Jury Seated in C.R. Bard Federal Transvaginal Mesh Trial

Jul 8th, 2013 | By
Jury Seated in C.R. Bard Federal Transvaginal Mesh Trial

July 8, 2013~ Telling the courtroom that California would take three weeks to seat a jury, West Virginia U.S. District Court Judge Joseph R. Goodwin had a jury selected in just two hours in the first federal case naming a manufacturer of transvaginal mesh. C.R. Bard, maker of Avaulta meshes, is named as a defendant
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.